Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Expert Review of Clinical Pharmacology|July 16, 2019
Therapeutic drug monitoring-based dosing of TNF inhibitors in inflammatory bowel disease: the way forward?Anne S Strik, Sophie E Berends, Mark Löwenberg
Expert Review of Gastroenterology & Hepatology|March 10, 2017
Golimumab for moderate to severe ulcerative colitisAnne S Strik, Sophie E Berends, Ron A Mathôt, et al.
Clinical Pharmacokinetics|May 13, 2018
Clinical Pharmacokinetic and Pharmacodynamic Considerations in the Treatment of Ulcerative ColitisSophie E Berends, Anne S Strik, Mark Löwenberg, et al.
Therapeutic Drug Monitoring|July 22, 2021
Population Pharmacokinetics of Infliximab in Children with Juvenile Idiopathic ArthritisAmara Nassar-Sheikh Rashid, Dieneke Schonenberg-Meinema, Sophie E Berends, et al.
Therapeutic Drug Monitoring|March 13, 2018
Explaining Interpatient Variability in Adalimumab Pharmacokinetics in Patients With Crohn's DiseaseSophie E Berends, Anne S Strik, Juliet C Van Selm, et al.
British Journal of Clinical Pharmacology|March 31, 2019
Dried blood samples can support monitoring of infliximab concentrations in patients with inflammatory bowel disease: A clinical validationSophie E Berends, Geert R A M D'Haens, Tiny Schaap, et al.
Journal of Pharmacokinetics and Pharmacodynamics|September 7, 2019
Tumor necrosis factor-mediated disposition of infliximab in ulcerative colitis patientsSophie E Berends, Tamara J van Steeg, Maurice J Ahsman, et al.
Therapeutic Drug Monitoring|August 30, 2019
Monitoring of Adalimumab Concentrations at Home in Patients with Inflammatory Bowel Disease Using Dried Blood SamplesSophie E Berends, Karien Bloem, Annick de Vries, et al.
Scandinavian Journal of Gastroenterology|May 28, 2019
Pharmacokinetics of golimumab in moderate to severe ulcerative colitis: the GO-KINETIC studySophie E Berends, Anne S Strik, Jeroen M Jansen, et al.
Drug Discovery Today|November 28, 2024
Stimulating development of innovative medicines in the European Union: does a new definition for unmet medical need add value?Lourens T Bloem, Hubert G M Leufkens, Sophie E Berends, et al.
Pageof 2